Nuwellis (NUWE) Total Current Liabilities (2011 - 2026)
Nuwellis' (NUWE) quarterly Total Current Liabilities came in at $3.7 million in Q1 2026, up 35.69% YoY from $2.7 million in Q1 2025, and up 23.02% on a QoQ basis from $3.0 million in Q4 2025.
Nuwellis (NUWE) Total Current Liabilities (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has 16 years of Total Current Liabilities data on file, last reported at $3.7 million in Q1 2026.
- Quarterly Total Current Liabilities rose 35.69% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 35.69% YoY) and the FY2025 annual result came in at $3.0 million, up 18.48% from the prior year.
- Total Current Liabilities improved to $3.7 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $4.7 million in Q4 2022 to a low of $2.6 million in Q4 2024.
- A 5-year average of $3.5 million and a median of $3.5 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 41.76% — and 2025, when it tumbled 36.41%.
- Tracing NUWE's Total Current Liabilities over 5 years: stood at $4.7 million in 2022, then tumbled by 32.34% to $3.2 million in 2023, then declined by 19.33% to $2.6 million in 2024, then rose by 18.48% to $3.0 million in 2025, then climbed by 23.02% to $3.7 million in 2026.
- The last three Total Current Liabilities figures came in at $3.7 million (Q1 2026), $3.0 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Nuwellis | 204,804.59 | -3.72 Mn | 1.50 Mn | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.01 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.89 Mn |
| Mar 31, 2025 | 2.75 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 2.99 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 4.11 Mn |
| Dec 31, 2022 | 4.69 Mn |
| Sep 30, 2022 | 3.61 Mn |
| Jun 30, 2022 | 3.46 Mn |
| Mar 31, 2022 | 3.39 Mn |
| Dec 31, 2021 | 3.31 Mn |
| Sep 30, 2021 | 3.80 Mn |